- More than 54,000,000 total prevalent cases of PCOS are expected in 2024 in the 16 countries covered in the publisher's epidemiology forecast for PCOS.
 - Marketed drugs for PCOS are widely genericized and the majority of drugs indicated to treat PCOS belong to gonadotropin class.
 - Out of 18 drugs in the pipeline for PCOS, only three are in the Phase III stage of development.
 - In the last 10 years, 832 trials have been initiated for PCOS. The highest number of trials were initiated in 2023, with 110 trials.
 - In deals involving companies developing PCOS assets that occurred during past 10 years, Partnership was found to be the most dominant deal type in most geographies.
 
Scope
The publisher's PCOS: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.Components of the report include -
- Disease Landscape
 - Disease Overview
 - Epidemiology Overview
 - Treatment Overview
 - Marketed Products Assessment
 - Breakdown by Mechanism of Action, Route of Administration
 - Product Profiles with Sales Forecast
 - Pricing and Reimbursement Assessment
 - Annual Therapy Cost
 - Time to Pricing and Time to Reimbursement
 - Pipeline Assessment
 - Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
 - Product Profiles with Sales Forecast
 - Late-to-mid-stage Pipeline Drugs
 - Phase Transition Success Rate and Likelihood of Approval
 - Clinical Trials Assessment
 - Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
 - Enrolment Analytics, Site Analytics, Feasibility Analysis
 - Deals Landscape
 - Mergers, Acquisitions, and Strategic Alliances by Region
 - Overview of Recent Deals
 - Commercial Assessment
 - Key Market Players
 - Future Market Catalysts
 
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
 - Develop business strategies by understanding the trends shaping and driving the PCOS market.
 - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global PCOS market in the future.
 - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
 - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
 - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
 

